Pfanstiehl, Inc - Company & Market Research Reports

Pfanstiehl is a global leader in GMP-produced, high purity, injectable grade excipients and bioprocessing solutions. The company supplies the majority of the world’s leading biopharma firms with critical formulation components for their commercial manufacturing needs. It serves the pharmaceuticals, biotechnology, veterinary, and cosmetics markets. The company was founded in 1919 and is based in Waukegan, Illinois. Pfanstiehl is a former subsidiary of Ferro Corporation.


Pharmaceutical Excipients Global Market - Forecast to 2022 - Product Thumbnail Image

Pharmaceutical Excipients Global Market - Forecast to 2022

  • Report
  • 426 Pages
From
Pharmaceutical Chemicals - Product Thumbnail Image

Pharmaceutical Chemicals

  • Report
  • 497 Pages
From
Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - Product Thumbnail Image

Contract Manufacturing in Pharmaceutical Industry, 2015-2025

  • Report
  • 319 Pages
From
ADC Contract Manufacturing Market (2nd edition), 2015-2025 - Product Thumbnail Image

ADC Contract Manufacturing Market (2nd edition), 2015-2025

  • Report
  • 208 Pages
From
High Potency Active Pharmaceutical Ingredients (HPAPI) Global Market - Forecast to 2023 - Product Thumbnail Image

High Potency Active Pharmaceutical Ingredients (HPAPI) Global Market - Forecast to 2023

  • Report
  • 226 Pages
From
Antibody Drug Conjugates Market (3rd Edition) - Product Thumbnail Image

Antibody Drug Conjugates Market (3rd Edition)

  • Report
  • 357 Pages
From
Antibody Drug Conjugates Market (4th Edition) 2017-2030 - Product Thumbnail Image

Antibody Drug Conjugates Market (4th Edition) 2017-2030

  • Report
  • 556 Pages
From
HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026 - Product Thumbnail Image

HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026

  • Report
  • 345 Pages
From
  • 8 Results (Page 1 of 1)
Loading Indicator
adroll